Drug Profile
Pyrilutamide - Suzhou Kintor Pharmaceuticals
Alternative Names: Androgen receptor antagonist 2; EX-A5504; HY-145451; KX 826; SCHEMBL1444126Latest Information Update: 21 Sep 2023
Price :
$50
*
At a glance
- Originator Suzhou Kintor Pharmaceuticals
- Class Antiacnes; Aza compounds; Benzamides; Fluorobenzenes; Foot disorder therapies; Imidazolidines; Nitriles; Skin disorder therapies; Small molecules
- Mechanism of Action Androgen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Alopecia
- Phase II Acne
- Discontinued Diabetic foot ulcer
Most Recent Events
- 28 Aug 2023 Efficacy and adverse event data from phase I/II trial in Acne released by Kintor Pharmaceutical
- 19 Jul 2023 Kintor Pharma initiates enrolment in its phase III trial for Alopecia in China (Topical)
- 11 May 2023 Suzhou Kintor Pharmaceutical completes a phase II trial for Alopecia (In adults, In the elderly) in USA (Topical)